Shopping Cart
- Remove All
- Your shopping cart is currently empty
Nevadistinel (NYX-458; NYX-3054) is a positive allosteric modulator of the N-methyl-D-aspartate (NMDA) receptor, indicated for mitigating cognitive deficits related to neurodegenerative conditions, including mild cognitive impairment, mild Alzheimer's disease, Parkinson's disease, and Lewy body disease [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $717 | 8-10 weeks | |
5 mg | $1,490 | 8-10 weeks | |
10 mg | $1,980 | 8-10 weeks | |
25 mg | $2,960 | 8-10 weeks | |
50 mg | $3,970 | 8-10 weeks | |
100 mg | $5,500 | 8-10 weeks |
Description | Nevadistinel (NYX-458; NYX-3054) is a positive allosteric modulator of the N-methyl-D-aspartate (NMDA) receptor, indicated for mitigating cognitive deficits related to neurodegenerative conditions, including mild cognitive impairment, mild Alzheimer's disease, Parkinson's disease, and Lewy body disease [1]. |
Alias | NYX-458, NYX-3054 |
Molecular Weight | 274.32 |
Formula | C15H18N2O3 |
Cas No. | 2181816-92-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.